327 related articles for article (PubMed ID: 12024920)
1. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.
Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T
Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920
[TBL] [Abstract][Full Text] [Related]
2. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A
APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751
[TBL] [Abstract][Full Text] [Related]
5. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
7. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
9. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
Liu XP; Fan SR; Peng YT; Zhang HP
J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
12. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
[TBL] [Abstract][Full Text] [Related]
13. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens.
Ellabib MS; ElJariny IA
Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942
[TBL] [Abstract][Full Text] [Related]
15. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Yang YL; Li SY; Cheng HH; Lo HJ;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
[TBL] [Abstract][Full Text] [Related]
17. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women.
al-Rawi N; Kavanagh K
Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049
[TBL] [Abstract][Full Text] [Related]
19. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
Sojakova M; Liptajova D; Borovsky M; Subik J
Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
